Talon Resources Targets Ontario Gold Growth After AIM Move and Eagle Lake Acquisition, CEO Says.Watch here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSCPA.L Regulatory News (SCPA)

  • There is currently no data for SCPA

Director/PDMR Notification

18 Sep 2020 09:47

RNS Number : 4313Z
Scapa Group PLC
18 September 2020
 

18 September 2020

LEI No. 213800QIPVTK5ES5UU36

SCAPA GROUP PLC

('the Company')

 

Director/PDMR Notification

 

Notification and public disclosure of transactions by persons discharging managerial responsibilities ('PDMR')

Scapa Group plc (AIM: SCPA) today announces that on 16 September 2020, the PDMRs named below were each granted nil cost options, under the Scapa Group plc 2019 Long Term Incentive Plan ('LTIP'), in respect of the number of ordinary shares of 5p each ('Ordinary Shares') shown alongside their respective names.

 Name / Position of PDMR

Number of Ordinary Shares over which the option is held

Oskar Zahn - Chief Financial Officer

300,172

John Petreanu - President Healthcare

254,113

Brett Pollard - MD Global Corporate Dev & Strategy

75,043

Wendy Baker - Group General Counsel and CoSec

145,798

In accordance with the rules of the LTIP, no consideration was paid by the above-named individuals for the option granted to him/her. Each option is subject to, and governed by, the rules of the LTIP and the legislation relating to the LTIP.

This announcement, including the notifications below, is made in accordance with the requirements of the EU Market Abuse Regulation.

ANNEX

1

Details of the person discharging managerial responsibilities / person closely associated

 

a)

Name

Oskar Zahn

 

2

Reason for the notification

 

a)

Position / status

Chief Financial Officer

 

b)

Initial notification / amendment

Initial notification

 

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

 

a)

Name

Scapa Group plc

 

b)

LEI

 

213800QIPVTK5ES5UU36

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; (iv) each place where transactions have been conducted

 

a)

Description of financial instrument,

type of instrument

Ordinary Shares of 5p each

 

Identification Code

 

GB0007281198

b)

Nature of the transaction

Grant of share option

 

c)

Price(s) and volume(s)

 

300,172 Ordinary Shares

Exercise price 0p

d)

Aggregated information

- Aggregated volume

- Price

 

n/a

e)

Date of the transaction

16 September 2020

 

f)

Place of the transaction

Off Market

 

 

1

Details of the person discharging managerial responsibilities / person closely associated

 

a)

Name

John Petreanu

 

2

Reason for the notification

 

a)

Position / status

President, Healthcare

 

b)

Initial notification / amendment

Initial notification

 

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

 

a)

Name

Scapa Group plc

 

b)

LEI

 

213800QIPVTK5ES5UU36

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; (iv) each place where transactions have been conducted

 

a)

Description of financial instrument,

type of instrument

Ordinary Shares of 5p each

 

Identification Code

 

GB0007281198

b)

Nature of the transaction

Grant of share option

 

c)

Price(s) and volume(s)

 

254,113 Ordinary Shares

Exercise price 0p

d)

Aggregated information

- Aggregated volume

- Price

 

n/a

e)

Date of the transaction

 

16 September 2020

f)

Place of the transaction

 

Off Market

 

1

Details of the person discharging managerial responsibilities / person closely associated

 

a)

Name

Brett Pollard

 

2

Reason for the notification

 

a)

Position / status

MD, Global Corp Development & Strategy

 

b)

Initial notification / amendment

Initial notification

 

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

 

a)

Name

Scapa Group plc

 

b)

LEI

 

213800QIPVTK5ES5UU36

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; (iv) each place where transactions have been conducted

 

a)

Description of financial instrument,

type of instrument

Ordinary Shares of 5p each

 

Identification Code

 

GB0007281198

b)

Nature of the transaction

Grant of share option

 

c)

Price(s) and volume(s)

 

75,043 Ordinary Shares

Exercise price 0p

d)

Aggregated information

- Aggregated volume

- Price

 

n/a

e)

Date of the transaction

 

16 September 2020

f)

Place of the transaction

 

Off Market

 

1

Details of the person discharging managerial responsibilities / person closely associated

 

a)

Name

Wendy Baker

 

2

Reason for the notification

 

a)

Position / status

Group General Counsel and CoSec

 

b)

Initial notification / amendment

Initial notification

 

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

 

a)

Name

Scapa Group plc

 

b)

LEI

 

213800QIPVTK5ES5UU36

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; (iv) each place where transactions have been conducted

 

a)

Description of financial instrument,

type of instrument

Ordinary Shares of 5p each

 

Identification Code

 

GB0007281198

b)

Nature of the transaction

Grant of share option

 

c)

Price(s) and volume(s)

 

145,798 Ordinary Shares

Exercise price 0p

d)

Aggregated information

- Aggregated volume

- Price

 

n/a

e)

Date of the transaction

 

16 September 2020

f)

Place of the transaction

Off Market

 

 

 

For further information:

 

Scapa Group plc:

Wendy Baker +44 (0) 161 301 7400

Company Secretary

 

Numis Securities Limited: +44 (0) 20 7260 1000

Mark Lander/Freddie Barnfield

(Joint Broker/Nominated Adviser)

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DSHUWSWRRSUKARR
Date   Source Headline
1st Dec 201510:11 amRNSHolding(s) in Company
1st Dec 201510:10 amRNSHolding(s) in Company
30th Nov 201510:34 amRNSTotal Voting Rights
24th Nov 20157:00 amRNSInterim Results
3rd Nov 20154:55 pmRNSHolding(s) in Company
3rd Nov 20154:54 pmRNSShareholder Circular Posted
13th Oct 20157:00 amRNSTrading Statement
10th Sep 20151:03 pmRNSAdditional Listing
9th Sep 20159:48 amRNSHolding(s) in Company
1st Sep 20153:57 pmRNSBlocklisting Interim Review
1st Sep 20153:29 pmRNSAdditional Listing
11th Aug 20151:28 pmRNSAdditional Listing
10th Aug 20159:46 amRNSDirector/PDMR Shareholding
23rd Jul 20159:21 amRNSDirector/PDMR Shareholding
21st Jul 20157:00 amRNSAGM Statement
14th Jul 20153:56 pmRNSAdditional Listing
13th Jul 20151:26 pmRNSHolding(s) in Company
2nd Jul 201511:15 amRNSAdditional Listing
17th Jun 20157:00 amRNSHealthcare Site Visit
16th Jun 20159:15 amRNSAdditional Listing
10th Jun 20152:54 pmRNSHolding(s) in Company
5th Jun 20159:01 amRNSHolding(s) in Company
4th Jun 20159:31 amRNSHolding(s) in Company
3rd Jun 20158:59 amRNSHolding(s) in Company
27th May 20157:00 amRNSFinal Results
28th Apr 20153:27 pmRNSAdditional Listing
9th Apr 20157:00 amRNSTrading Statement
7th Apr 20154:38 pmRNSHolding(s) in Company
7th Apr 20153:43 pmRNSAdditional Listing
31st Mar 20159:12 amRNSTotal Voting Rights
30th Mar 20154:02 pmRNSAdditional Listing
30th Mar 20152:58 pmRNSDirector/PDMR Shareholding
18th Mar 20154:45 pmRNSHolding(s) in Company
16th Mar 20154:20 pmRNSAdditional Listing
10th Mar 20154:10 pmRNSAdditional Listing
9th Mar 20157:00 amRNSHolding(s) in Company
5th Mar 20157:00 amRNSDirector/PDMR Shareholding
5th Mar 20157:00 amRNSDirector/PDMR Shareholding
4th Mar 20157:00 amRNSDirector/PDMR Shareholding
2nd Mar 20153:58 pmRNSAdditional Listing
2nd Mar 20157:00 amRNSAcquisition
23rd Feb 20159:08 amRNSHolding(s) in Company
16th Feb 20159:01 amRNSHolding(s) in Company
13th Feb 20159:09 amRNSHolding(s) in Company
11th Feb 201510:52 amRNSHolding(s) in Company
9th Feb 20151:35 pmRNSHolding(s) in Company
9th Feb 201510:33 amRNSBlocklisting Interim Review
4th Feb 201512:18 pmRNSHolding(s) in Company
23rd Jan 20159:59 amRNSHolding(s) in Company
31st Dec 201412:02 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.